GOLDMAN SACHS GROUP INC - CITIUS PHARMACEUTICALS INC ownership

CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 78 filers reported holding CITIUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CITIUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$105,597
-63.7%
154,291
-36.4%
0.00%
Q2 2023$290,942
+2660.6%
242,452
+1717.5%
0.00%
Q4 2022$10,539
-94.8%
13,340
-94.0%
0.00%
Q2 2022$203,000
-24.0%
221,256
+48.5%
0.00%
Q1 2022$267,000
+196.7%
149,034
+155.3%
0.00%
Q4 2021$90,000
-77.6%
58,386
-70.4%
0.00%
Q3 2021$401,000
+1.3%
197,121
+73.3%
0.00%
Q2 2021$396,000
+1000.0%
113,764
+882.9%
0.00%
Q3 2017$36,00011,5740.00%
Other shareholders
CITIUS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Key Bridge Compliance, LLC 154,130$105,4870.03%
CHELSEA COUNSEL CO 81,300$55,6420.03%
Inspire Advisors, LLC 186,410$127,5790.02%
Horst & Graben Wealth Management LLC 75,722$51,8240.01%
GSA CAPITAL PARTNERS LLP 198,492$1360.01%
Arkadios Wealth Advisors 100,000$68,4400.01%
Miller Investment Management, LP 50,000$34,2200.01%
XTX Topco Ltd 29,077$19,9000.00%
Measured Wealth Private Client Group, LLC 10,000$6,8440.00%
Pasadena Private Wealth, LLC 10,965$7,5040.00%
View complete list of CITIUS PHARMACEUTICALS INC shareholders